Hangzhou Wensli Silk Culture
301066
Yoantion Industrial Inc.,
301053
Xinlei Compressor
301317
4
QIFENG
873169
5
LAISAI LASER
871263
CN Stock MarketDetailed Quotes
301096 Hangzhou Bio-Sincerity Pharma-Tech
- 34.98
- +0.61+1.77%
Market Closed May 9 15:00 CST
3.82BMarket Cap-29.67P/E (TTM)
35.47High34.17Low32.34KlotVolume34.42Open34.37Pre Close112.76MTurnover4.66%Turnover RatioLossP/E (Static)109.23MShares69.4052wk High1.50P/B2.43BFloat Cap30.6052wk Low41.24Limit Up69.43MShs Float118.30Historical High27.50Limit Down3.78%Amplitude30.60Historical Low0.30Dividend TTM34.86Avg Price14.44KlotAsk0.86%Div YieldTTM100Lot Size16.62KlotBid
Hangzhou Bio-Sincerity Pharma-Tech Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -3.31%98.68M | -16.30%575.16M | -10.59%419M | -11.41%280.71M | -27.82%102.05M | 26.88%687.13M | 24.87%468.65M | 32.87%316.87M | 99.31%141.39M | 41.21%541.57M |
| Refunds of taxes and levies | ---- | 17.19%33.23M | -12.96%22.16M | 39.19%22.16M | -100.00%11.01 | -58.23%28.36M | -66.96%25.46M | -79.36%15.92M | -55.45%7.04M | --67.88M |
| Cash received relating to other operating activities | 13.49%10.05M | -53.32%43.65M | -46.44%34.85M | 93.87%36.13M | 6.99%8.85M | 24.66%93.51M | 27.75%65.07M | -51.72%18.63M | -52.57%8.28M | 416.44%75.02M |
| Cash inflows from operating activities | -1.97%108.73M | -19.40%652.04M | -14.87%476.01M | -3.54%338.99M | -29.23%110.91M | 18.19%809M | 11.11%559.18M | -0.79%351.42M | 50.40%156.71M | 71.96%684.47M |
| Goods services cash paid | -27.12%55.83M | 19.72%316.57M | 32.52%236.71M | 34.58%153.13M | 47.70%76.61M | 158.92%264.42M | 71.36%178.62M | 52.84%113.79M | 27.80%51.87M | 22.44%102.13M |
| Staff behalf paid | -26.22%84.35M | 24.58%342.69M | 29.38%265.99M | 34.67%187.98M | 38.25%114.33M | 45.45%275.06M | 51.67%205.58M | 58.69%139.58M | 65.90%82.7M | 74.58%189.12M |
| All taxes paid | 1.32%9.24M | -4.54%27.97M | 24.57%25.17M | 13.77%19.61M | 42.81%9.12M | 12.50%29.3M | -58.53%20.2M | -62.19%17.23M | -39.42%6.38M | 54.74%26.04M |
| Cash paid relating to other operating activities | -10.61%29.34M | 7.28%160.67M | 8.23%131.2M | -9.27%73.16M | 71.59%32.82M | 38.96%149.76M | 112.20%121.23M | 96.07%80.64M | -47.28%19.13M | 144.67%107.77M |
| Cash outflows from operating activities | -23.24%178.76M | 18.00%847.9M | 25.38%659.07M | 23.53%433.88M | 45.48%232.88M | 69.05%718.55M | 52.08%525.64M | 40.99%351.25M | 16.63%160.08M | 68.26%425.06M |
| Net cash flows from operating activities | 42.59%-70.03M | -316.53%-195.86M | -645.85%-183.06M | -53,749.41%-94.89M | -3,522.23%-121.98M | -65.13%90.45M | -78.73%33.54M | -99.83%176.87K | 89.81%-3.37M | 78.38%259.41M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | -86.36%1.36M | ---- | ---- | ---- | --10M | --11.65M | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --16.29K | ---- | 1,118.27%2.98M | ---- | ---- | -57.37%234.56K | 5,123.64%245K | 10,584.28%501.12K | ---- | 3,553.21%550.21K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | --45.98M | --44.33M | --44.33M | ---- | ---- |
| Cash received relating to other investing activities | 30.73%128.02M | 405.37%472.53M | 625.92%201.25M | 325.58%117.98M | 253.25%97.93M | 1,180.61%93.5M | 593.09%27.72M | 593.09%27.72M | --27.72M | -92.00%7.3M |
| Cash inflows from investing activities | 30.74%128.03M | 238.22%472.53M | 149.83%205.6M | 40.12%117.98M | 253.25%97.93M | 1,679.42%139.71M | 1,954.97%82.29M | 2,002.56%84.2M | 590,940.56%27.72M | -91.40%7.85M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -82.01%40.59M | -42.62%395.1M | -23.61%392.87M | -12.53%319.43M | 17.77%225.61M | 16.40%688.6M | 14.17%514.28M | 34.85%365.17M | 79.87%191.57M | 138.11%591.58M |
| Cash paid to acquire investments | 0.00%5M | 16.87%61.12M | -57.01%23.12M | -62.04%15M | -46.37%5M | -31.30%52.29M | 280.03%53.77M | 265.91%39.52M | 832.40%9.32M | --76.12M |
| Net cash paid to acquire subsidiaries and other business units | ---- | --13.43M | --13.43M | --13.43M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | 70.56%171.22M | 181.18%467.42M | 271.36%339.61M | 145.59%152.81M | 177.96%100.39M | 435.85%166.24M | 1,224.38%91.45M | 4,794.70%62.22M | --36.12M | -67.00%31.02M |
| Cash outflows from investing activities | -34.50%216.82M | 3.30%937.07M | 16.61%769.03M | 7.23%500.67M | 39.66%331M | 29.83%907.13M | 39.88%659.51M | 65.07%466.91M | 120.46%237.01M | 104.04%698.72M |
| Net cash flows from investing activities | 61.91%-88.79M | 39.47%-464.54M | 2.39%-563.43M | 0.01%-382.68M | -11.37%-233.07M | -11.08%-767.42M | -23.47%-577.21M | -37.24%-382.71M | -94.68%-209.28M | -175.07%-690.87M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | -57.30%9.38M | --9.38M | --490K | ---- | --21.98M | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | --490K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | -61.09%200M | 165.32%1.24B | 129.10%664.4M | 133.71%654.4M | 105.60%514M | 56.33%469M | --290M | --280M | --250M | 127.71%300M |
| Cash inflows from financing activities | -61.09%200M | 155.35%1.25B | 132.34%673.78M | 133.89%654.89M | 105.60%514M | 63.66%490.98M | --290M | --280M | --250M | -85.17%300M |
| Borrowing repayment | -67.94%80M | 805.50%905.5M | --435M | --350M | --249.5M | -82.36%100M | ---- | ---- | ---- | 2,884.06%566.97M |
| Dividend interest payment | 31.29%4.24M | -47.45%48.77M | -51.04%44.42M | -54.92%40.03M | 3,909.83%3.23M | 39.45%92.81M | 37.03%90.74M | 34.27%88.8M | -92.86%80.56K | 557.28%66.55M |
| Cash payments relating to other financing activities | 505.97%105.09K | -97.47%1.36M | -97.32%990.26K | -96.41%102.29K | -99.34%17.34K | 62.93%53.69M | 17.89%36.9M | -90.33%2.85M | -81.61%2.63M | 196.07%32.95M |
| Cash outflows from financing activities | -66.63%84.35M | 287.69%955.63M | 276.39%480.41M | 325.68%390.14M | 9,237.53%252.75M | -63.02%246.49M | -64.67%127.64M | -71.41%91.65M | -98.87%2.71M | 1,555.63%666.48M |
| Net cash flows from financing activities | -55.73%115.65M | 21.93%298.09M | 19.10%193.37M | 40.57%264.75M | 5.64%261.25M | 166.71%244.48M | 144.94%162.36M | 158.75%188.35M | 202.86%247.29M | -118.49%-366.48M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -2,088.86%-30.41K | 109.64%12.97K | 102.72%1.72K | 99.26%-452.59 | ---1.39K | ---134.5K | -632,631,200.00%-63.26K | ---61.14K | ---- | ---- |
| Net increase in cash and cash equivalents | 53.95%-43.19M | 16.26%-362.29M | -45.03%-553.11M | -9.56%-212.82M | -370.79%-93.8M | 45.78%-432.62M | 43.17%-381.38M | 60.71%-194.24M | 109.09%34.64M | -142.52%-797.93M |
| Add:Begin period cash and cash equivalents | -46.54%416.16M | -35.72%778.45M | -35.72%778.45M | -35.72%778.45M | -35.72%778.45M | -39.72%1.21B | -39.72%1.21B | -39.72%1.21B | -39.72%1.21B | 1,415.03%2.01B |
| End period cash equivalent | -45.52%372.97M | -46.54%416.16M | -72.84%225.34M | -44.37%565.64M | -45.04%684.65M | -35.72%778.45M | -37.98%829.69M | -32.87%1.02B | -23.48%1.25B | -39.72%1.21B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.